Wipro Technologies, an IT and consulting and outsourcing firm of Wipro Ltd. Announced a cloud based productized solution to help its customer base of drug development owners (Sponsors), CRO (Clinical Research Organizations) clinical sites and regulators to improve collaboration capabilities for multi-region clinical trials, said a press release on Friday.
The Wipro Clinical Collaboration Portal will decrease the clinical trial cycle time by 20-30 per cent by accelerating up communication and document exchanges between all the stakeholders including the sponsor organization, the staff of the CRO along with clinical site coordinators and principal investigators.
This Portal platform can be benefited as an enterprise level solution to increase efficiency and lower the cost of clinical operations, the company added.
The portal has the ability to improved manage all the data required to conduct a clinical trial that makes up the trial master file which, in the existing clinical trial model, is dominantly paper based in combination with shared folders across geographies.
Through inculcation of a common SOP (Standard Operating Procedure) across the groups which are involved in clinical trials, the Wipro Clinical Collaboration portal helps them to better adhere to regulatory frameworks such as Good Clinical Practice (GCP) guidelines to avoid any oversight in the trial management process, claimed the company.
“The Wipro Clinical Collaboration cloud-based portal is supported by Wipro’s Rapid Trial framework and very well integrated with leading market products for Electronic Data Capture (EDC), Interactive Voice Recording System (IVRS), Safety, electronic Trial Master File, document management systems and Clinical Trial Management System (CTMS) solutions with a zero CAPEX in a highly compliant, best-in-class system,” said R Srinivas Rao, VP and vertical head – Life Sciences Solutions, Wipro.
A platform which enables the exchange of documents and communication in compliance with global standards, while performing the clinical trials really relieves our customers from worrying about the compliance and validation of any solution used in the clinical trial space and helps them focus better on core trial conduct and efficiency, he concluded.